The Impact of Compound Probiotic Freeze-dried Powder on Enhancing Gastrointestinal Health
1 other identifier
interventional
100
1 country
1
Brief Summary
The primary objective of this study is to evaluate the effects of the compound probiotic freeze-dried powder on gastrointestinal function and its impact on gut microbiota, immune factors, inflammatory markers, and intestinal barrier function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 12, 2025
CompletedFirst Submitted
Initial submission to the registry
June 16, 2025
CompletedFirst Posted
Study publicly available on registry
June 18, 2025
CompletedJune 18, 2025
June 1, 2025
9 months
June 16, 2025
June 16, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Improvement of gastrointestinal symptoms
Bowel movement frequency improvement: use the "bowel movement frequency scale"
4 weeks
Study Arms (2)
Wec120B group
EXPERIMENTALWec300B group
EXPERIMENTALInterventions
Probiotic strips with different strain formulas, Specification: 2g/bag. Storage method: Keep away from light, seal tightly, and store in a cool, dry place.
Eligibility Criteria
You may qualify if:
- (1)Age: 18-65; (2)It conforms to the diagnostic criteria for gastrointestinal dysfunction formulated in the "Expert Consensus on Precision Health Communication in China - Guidelines for Citizens' Intestinal Health"; (3)Symptoms: Irregular defecation, loose or hard stools; Intestinal rumbling in the abdomen Abdominal distension Hiccups, belching; Severe intestinal flatulence; Abdominal pain Acid reflux and heartburn; Pain in the stomach or abdomen when hungry; Disgusting; (4) Signs: Abdominal pain and abdominal distension; Diarrhea and constipation Indigestion Gastric acid reflux Bad breath and farting smell; Skin problems The color and shape of the stool have changed.
You may not qualify if:
- (1)Drugs that affect the intestinal flora (including antibacterial drugs, microecological preparations, intestinal mucosal protectants, traditional Chinese patent medicines, etc.) should be used continuously for more than one week within one month before screening; (2)Recent use of products with similar functions to the test product, which may interfere with the judgment of the study results; (3) use of antibiotics during illness; (3)Use of antibiotics during illness; (4)Resence of severe systemic diseases or malignant tumors; (5)allergy to any components of the probiotics used in the study; (6)women who are pregnant, breastfeeding, or planning to conceive in the near future.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Food and Bioengineering, Henan University of Science and Technology
Luoyang, Henan, 471000, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 16, 2025
First Posted
June 18, 2025
Study Start
August 30, 2024
Primary Completion
June 10, 2025
Study Completion
June 12, 2025
Last Updated
June 18, 2025
Record last verified: 2025-06